OSH15 Antibody

What is OSH15 and why would researchers need antibodies targeting this protein?

OSH15 is a member of the knotted1-type homeobox gene family in rice (Oryza sativa) that plays crucial roles in internode development. Loss-of-function mutations in OSH15 result in specific shortening of the lower internodes, known as d6-type dwarfism . Researchers require antibodies against OSH15 to:

• Detect protein expression levels in different tissues and developmental stages

• Visualize protein localization within cells and tissues

• Investigate protein-protein interactions, particularly with DLT

• Study chromatin binding patterns to identify target genes

• Analyze post-translational modifications that may regulate OSH15 activity

The expression of OSH15 is particularly strong in lower internodes, especially IN2, with an expression pattern opposite to that of DLT . Antibodies allow researchers to confirm and expand on these expression data at the protein level.

How can researchers validate the specificity of OSH15 antibodies?

Validating antibody specificity is critical for obtaining reliable research data. For OSH15 antibodies, researchers should employ multiple validation approaches:

• Genetic controls: Test antibody reactivity in wild-type tissues versus osh15 mutant tissues. The search results mention several loss-of-function mutations in OSH15, including the d6 mutant , which provide excellent negative controls.

• Western blot analysis: Confirm a single band of the expected molecular weight (predicted from the amino acid sequence of OSH15).

• Immunoprecipitation followed by mass spectrometry: Verify that the immunoprecipitated protein is indeed OSH15.

• Reactivity with recombinant protein: Test antibody reactivity against purified recombinant OSH15 protein.

• siRNA or CRISPR knockdown: Demonstrate reduced antibody signal following experimental reduction of OSH15 expression.

What expression patterns should researchers expect when using OSH15 antibodies in rice tissues?

Based on the provided research data, researchers using OSH15 antibodies should expect distinct expression patterns:

Researchers should note that OSH15 mRNA is localized just below the leaf insertion points and at the primordia of axillary buds, with a ring-shaped expression pattern in cross-sections through planes of leaf insertions . Antibody staining should generally correspond to these mRNA patterns.

What are the recommended protocols for using OSH15 antibodies in co-immunoprecipitation experiments?

Co-immunoprecipitation (Co-IP) is crucial for studying OSH15 protein interactions, particularly with DLT. Based on published research methodologies:

• Tissue selection: Choose tissues with high OSH15 expression (internodes, particularly IN2) for optimal protein yield .

• Protein extraction:

  • Use a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5% glycerol, 1% Triton X-100, protease inhibitor cocktail, and phosphatase inhibitors.

  • Include 1-2 mM DTT to preserve protein structure.

  • Extract tissues at 4°C to minimize protein degradation.

• Co-IP procedure:

  • Pre-clear lysates with protein A/G beads.

  • Incubate with OSH15 antibody (or control IgG) overnight at 4°C.

  • Add fresh protein A/G beads and incubate for 2-3 hours.

  • Wash extensively to remove non-specific binding.

  • Elute and analyze by Western blot using antibodies against potential interacting proteins.

Previous research successfully used this approach to confirm the interaction between DLT and OSH15 using GFP/FLAG-tagged fusion proteins , which supports the viability of antibody-based Co-IP approaches.

How can OSH15 antibodies be employed in chromatin immunoprecipitation (ChIP) assays?

Given that OSH15 forms a complex with DLT that directly binds the promoter of OsBRI1 , ChIP assays using OSH15 antibodies are valuable for identifying genomic binding sites:

• Cross-linking: Fix rice tissues (preferably internodes) with 1% formaldehyde for 10-15 minutes.

• Chromatin preparation:

  • Extract nuclei and sonicate to shear chromatin (aim for fragments of 200-500 bp).

  • Confirm fragmentation by agarose gel electrophoresis.

• Immunoprecipitation:

  • Pre-clear chromatin with protein A/G beads.

  • Incubate with OSH15 antibody overnight at 4°C.

  • Include appropriate controls (IgG, input).

• Washing and elution:

  • Use increasingly stringent wash buffers to remove non-specific binding.

  • Elute bound DNA and reverse cross-links.

• Analysis:

  • Perform qPCR for known targets (e.g., OsBRI1 promoter).

  • For discovery, sequence immunoprecipitated DNA (ChIP-seq).

When analyzing results, researchers should focus on promoters of genes involved in brassinosteroid biosynthesis and signaling pathways, given OSH15's role in these processes.

What considerations should be made when designing antibodies against different domains of OSH15?

When developing domain-specific antibodies against OSH15, researchers should consider:

• Functional domains: OSH15 contains a homeodomain responsible for DNA binding . Antibodies against this domain might interfere with DNA binding in functional assays.

• Protein interaction regions: OSH15 interacts with DLT through specific domains . Carefully select epitopes that won't block protein-protein interactions if studying these complexes.

• Conservation concerns: The homeodomain is highly conserved among knotted1-type proteins. Design antibodies against unique regions to avoid cross-reactivity.

• Post-translational modification sites: Consider whether potential phosphorylation or other modifications might affect antibody binding.

• Subcellular localization signals: OSH15 shows both nuclear and cytoplasmic localization , suggesting it may contain nuclear localization signals that could be important epitopes.

What are the optimal protein extraction methods for preserving OSH15 structure?

Given OSH15's role as a transcription factor with multiple interaction partners, maintaining protein structure during extraction is crucial:

• Buffer composition:

  • Use 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5% glycerol, and 0.1-1% non-ionic detergent (NP-40 or Triton X-100).

  • Include protease inhibitor cocktail to prevent degradation.

  • Add 1-2 mM DTT or β-mercaptoethanol to maintain disulfide bonds.

  • Consider adding phosphatase inhibitors to preserve potential phosphorylation states.

• Extraction conditions:

  • Perform all steps at 4°C to minimize protein degradation.

  • Use gentle homogenization methods to prevent protein denaturation.

  • Clarify lysates by centrifugation at 12,000-15,000 × g for 10-15 minutes.

• Tissue selection:

  • Based on expression data, internodes (particularly IN2) are optimal for high OSH15 yield .

  • Consider developmental stage carefully, as OSH15 expression varies temporally.

• Storage considerations:

  • Aliquot extracts to avoid freeze-thaw cycles.

  • Store at -80°C for long-term preservation.

How can immunohistochemistry with OSH15 antibodies reveal spatial expression patterns?

Given OSH15's differential expression across rice internodes, immunohistochemistry (IHC) is valuable for spatial localization studies:

• Tissue preparation:

  • Fix tissues in 4% paraformaldehyde in phosphate buffer.

  • For paraffin embedding, follow the protocol described in previous research: fix with paraformaldehyde/glutaraldehyde and embed in Paraplast Plus .

  • Section tissues at 7-10 μm thickness for optimal antibody penetration .

• Antigen retrieval:

  • Heat-induced epitope retrieval in citrate buffer (pH 6.0) may improve antibody binding.

  • Enzymatic retrieval with proteinase K can be considered as an alternative.

• Immunostaining procedure:

  • Block with 5% BSA or normal serum from the species of the secondary antibody.

  • Incubate with primary OSH15 antibody overnight at 4°C.

  • Apply fluorescent-labeled or enzyme-conjugated secondary antibodies.

  • Include DAPI staining to visualize nuclei, where strong OSH15 signals are expected .

• Controls and analysis:

  • Include osh15 mutant tissues as negative controls.

  • Compare results with previously reported expression patterns, such as the ring-shaped pattern observed in cross-sections .

  • Pay particular attention to parenchyma cells, where OSH15 is specifically expressed .

What controls should be included when performing Western blot analysis using OSH15 antibodies?

Proper controls are essential for reliable Western blot results:

• Positive controls:

  • Recombinant OSH15 protein at known concentrations

  • Protein extracts from tissues with high OSH15 expression (IN2)

  • Extracts from plants overexpressing OSH15

• Negative controls:

  • Extracts from osh15 loss-of-function mutants (e.g., d6 mutant)

  • Tissues with minimal OSH15 expression (based on mRNA data)

  • Pre-immune serum controls

• Loading controls:

  • Constitutively expressed proteins (actin, tubulin, GAPDH)

  • Total protein staining (Ponceau S, Coomassie)

• Specificity controls:

  • Peptide competition assay (pre-incubation of antibody with immunizing peptide)

  • Secondary antibody-only controls to detect non-specific binding

• Technical considerations:

  • Include molecular weight markers to confirm band size

  • Run gradient gels for better separation of proteins

  • Use positive control tissues from different developmental stages to account for potential post-translational modifications

How can OSH15 antibodies help investigate the OSH15-DLT protein complex formation?

The interaction between OSH15 and DLT proteins forms a complex that regulates brassinosteroid signaling . OSH15 antibodies can help characterize this complex:

• Reciprocal co-immunoprecipitation assays:

  • Perform Co-IP with OSH15 antibodies and probe for DLT.

  • Perform Co-IP with DLT antibodies and probe for OSH15.

  • Compare the efficiency of complex isolation from different internodes given their opposite expression patterns.

• Proximity ligation assay (PLA):

  • Use OSH15 and DLT antibodies from different species.

  • Apply species-specific secondary antibodies with complementary oligonucleotides.

  • Visualize protein interactions in situ through fluorescent signals generated when proteins are in close proximity.

• Size exclusion chromatography with immunodetection:

  • Fractionate protein complexes by size.

  • Analyze fractions by Western blot using OSH15 and DLT antibodies.

  • Identify fractions containing both proteins to confirm complex formation.

• Fluorescence resonance energy transfer (FRET):

  • Label OSH15 and DLT antibodies with appropriate fluorophore pairs.

  • Measure energy transfer as an indicator of protein proximity.

• Analysis considerations:

  • Compare complex formation in different internodes, as expression patterns of OSH15 and DLT are opposite .

  • Investigate how complex formation correlates with BR signaling by analyzing OsBRI1 expression in the same tissues.